|
|
Lab Updates |
|
| Follow us on Twitter » | |
|
The control of these signals requires very fine tuning. This is regulated by shape changes in the integrin molecules. In simple terms, one shape corresponds to an integrin that is switched off and another shape to an integrin that is switched on. Research is being performed to understand exactly how these shapes changes happen, how they are translated into signals and how the signals tell a cell what to do in response. Sometimes signalling by integrins goes wrong, which can lead to disease. When integrins malfunction, cells start to move and stick in the wrong place. These mistakes can result in conditions like blocked arteries and heart disease, secondary cancerous tumours and certain autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. A detailed understanding of how integrin signalling works can potentially lead to the manufacture of new medicines to treat these life-threatening disorders. |
|
We believe that syndecan-4 may be acting like a compass, directing which way the cell goes. If we delete the syndecan-4 gene so that it is no longer present on the cell surface, the cell no longer has a single front and tail but instead has several at the same time. The cell becomes confused, and it moves around in circles rather than following a straight path. This may explain why mice lacking syndecan-4 have problems closing a wound. Our research aims to discover how the information collected by syndecan-4 is decoded within the cell and how syndecan-4 works in combination with integrins to cause the cell to change its shape, to move and to close a wound. |
Integrin proteomicsInformation about integrin proteomics will appear here soon. |
Fibronectin and other ECM moleculesInformation about fibronectin and other ECM molecules will appear here soon. |
Anti-integrin antibodiesInformation about anti-integrin antibodies will appear here soon. |